ALPINE2: Efficacy and safety of 14-day vs 28-day inhaled aztreonam for Pa eradication in children with cystic fibrosis
Titel:
ALPINE2: Efficacy and safety of 14-day vs 28-day inhaled aztreonam for Pa eradication in children with cystic fibrosis
Auteur:
Gilchrist, Francis J. Bui, Stephanie Gartner, Silvia McColley, Susanna A. Tiddens, Harm Ruiz, Gary Stehling, Florian Alani, Muhsen Gurtovaya, Oksana Bresnik, Mark Watkins, Timothy R. Frankovic, Biliana Skov, Marianne